Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Shobhana Vora"'
Publikováno v:
Journal of Applied Physiology. 70:391-398
Humans who lack availability of carbohydrate fuels may provide important models for the study of physiological control mechanisms. We compared seven patients who had unavailability of muscle glycogen and blood glucose as oxidative fuels due to muscle
Autor:
Shobhana Vora
Publikováno v:
Analytical Biochemistry. 144:307-318
Hybridoma antibodies are powerful tools. Their impact is already apparent in many areas of basic and applied research. In contrast, their impact is just beginning to be felt in enzymology. The existing literature on monoclonal antibodies to enzymes a
Publikováno v:
Proceedings of the National Academy of Sciences. 82:8109-8113
Mammalian phosphofructokinase (PFK; ATP:D-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11) exists in multimolecular forms, which result from random tetramerization of three distinct subunits, M (muscle-type), L (liver-type), and P (platelet-ty
Autor:
Shobhana Vora
Publikováno v:
Blood. 57:724-732
We have previously demonstrated that human red cell (RBC) phosphofructokinase (PFK) is under dual genetic control, since it is a mixture of five tetrameric isozymes composed of two distinct subunits, M (muscle-type) and L (liver-type), i.e., M4, M3L,
Publikováno v:
Biochemical Journal. 214:703-710
Human 6-phosphofructokinase (EC 2.7.1.11) exists in tetrameric isoenzymic forms composed of muscle (M), liver (L) and platelet (P) subunits, which are under separate genetic control. In the adult, the proportion of these subunits in different organs
Publikováno v:
Blood. 55:629-635
Normal human erythrocyte phosphofructokinase (ATP:c D-fructose-6, P-1- phosphotransferase, EC 2.7.1.11; PFK) has recently been shown to consist of a heterogeneous mixture of five tetrameric isozymes: M4, M3L, M2L2, ML3, and L4 (M, muscle type; L, liv
Publikováno v:
Blood. 58:823-829
Recently we have demonstrated that human phosphofructokinase (PFK; ATP: D-fructose-6-P, 1-phosphotransferase; EC.2.7.1.11) is under the control of three structural loci that code for M (muscle-type), L (liver-type), and P (platelet-type) subunits: ra
Autor:
Shobhana Vora, Uta Francke
Publikováno v:
Proceedings of the National Academy of Sciences. 78:3738-3742
Human 6-phosphofructokinase (PFK; ATP:D-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11) is under the control of structural loci that code for muscle (M), liver (L), and platelet (P) subunits, which are variably expressed in different tissues;
Publikováno v:
Human Genetics. 63:374-379
Human phosphofructokinase (PFK; EC 2.7.1.11) is under the control of three structural loci which encode muscle-type (M), liver-type (L), and platelet or fibroblast-type (P) subunits; human diploid fibroblasts and leukocytes express all three loci. In
Publikováno v:
Journal of Clinical Investigation. 72:545-550
Muscle cultures from three unrelated patients with muscle phosphofructokinase (PFK; EC 2.7.1.11) deficiency (Glycogenosis type VII; Tarui disease) had normal PFK activity and normal morphology. Chromatographic and immunological studies showed that no